Glycemic control and adherence to basal insulin therapy in Taiwanese patients with type 2 diabetes mellitus.

ABSTRACT:

Aims/introduction

The aim of the present study was to assess the glycemic control, adherence and treatment satisfaction in a real-world setting with basal insulin therapy in type 2 diabetes patients in Taiwan.

Materials and methods

This was a multicenter, prospective, observational registry. A total of 836 patients with type 2 diabetes taking oral antidiabetic drugs with glycated hemoglobin (HbA1c) >7% entered the study. Basal insulin was given for 24 weeks. All treatment choices and medical instructions were at the physician's discretion to reflect real-life practice.

Results

After 24-week treatment, 11.7% of patients reached set HbA1c goals without severe hypoglycemia (primary effectiveness end-point). HbA1c and fasting blood glucose were significantly decreased fro

SUBMITTER: Chien MN 

PROVIDER: S-EPMC5089951 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature